Gastrointestinal Neoplasms
"Gastrointestinal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
| Descriptor ID |
D005770
|
| MeSH Number(s) |
C04.588.274.476 C06.301.371 C06.405.249
|
| Concept/Terms |
Gastrointestinal Neoplasms- Gastrointestinal Neoplasms
- Gastrointestinal Neoplasm
- Neoplasm, Gastrointestinal
- Neoplasms, Gastrointestinal
Cancer of Gastrointestinal Tract- Cancer of Gastrointestinal Tract
- Gastrointestinal Tract Cancer
- Gastrointestinal Tract Cancers
- Cancer of the Gastrointestinal Tract
- Gastrointestinal Cancer
- Cancer, Gastrointestinal
- Cancers, Gastrointestinal
- Gastrointestinal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Gastrointestinal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Gastrointestinal Neoplasms".
This graph shows the total number of publications written about "Gastrointestinal Neoplasms" by people in this website by year, and whether "Gastrointestinal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrointestinal Neoplasms" by people in Profiles.
-
Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic. JAMA Netw Open. 2024 Mar 04; 7(3):e240160.
-
Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One. 2015; 10(10):e0140180.
-
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
-
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res. 1989 Oct 15; 49(20):5736-47.
-
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem. 1983 Mar; 29(3):549-52.